Pain Management, CYP450 2D6/2C19 Genotype, Qualitative

The Pain Management, CYP450 2D6/2C19 Genotype, Qualitative test contains 1 test with 3 biomarkers.

Identifies CYP2D6 and CYP2C genotypes to aid clinicians in determining therapeutic strategy and treatment dose for therapeutics that are metabolized by the CYP2D6 or CYP2C19 gene product.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Clopidogrel (CYP2C19 Genotyping), Clopidogrel Pharmacogenetic Testing, CYP2C19 Genotype, CYP2C19 Sequence Genotype, CYP2D6 Genotype, Pain Management CYP450 2D62C19 Genotype Qualitative

Cyp2c19 Genotype

Cyp2d6 Genotype

Laboratory Director

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.